| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.069 | 0.03 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.03 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.07 | 0.03 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.04 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.08 | 0.04 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.26 | 0.04 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.11 | 0.04 |